NCT00305890

Brief Summary

Osteoarthritis (OA) occurs when the cartilage between two bones becomes worn down, and the bones begin to rub against each other in the joint. This often leads to pain, swelling, decreased joint motion, and the formation of bone spurs (tiny growths of new bone). Being overweight increases the risk of developing OA and fastens disease progression. This study will evaluate two different programs, lifestyle behavioral weight management and pain-coping skills training, in reducing the effects of knee OA in obese individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
412

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2004

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2004

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

March 20, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 22, 2006

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2009

Completed
Last Updated

October 25, 2018

Status Verified

August 1, 2013

Enrollment Period

5.7 years

First QC Date

March 20, 2006

Last Update Submit

October 24, 2018

Conditions

Outcome Measures

Primary Outcomes (5)

  • Psychological impairment

    Measured immediately, 6 months, and 12 months following treatment: pain

  • Physical disability

    Measured immediately, 6 months, and 12 months following treatment: pain

  • Joint stiffness

    Measured immediately, 6 months, and 12 months following treatment: pain

  • Activity level

    Measured immediately, 6 months, and 12 months following treatment: pain

  • Physical activities

    Measured immediately, 6 months, and 12 months following treatment: pain

Secondary Outcomes (2)

  • Physiological measures of disease activity

    Measured immediately, 6 months, and 12 months following treatment: pain

  • Gait measures

    Measured immediately, 6 months, and 12 months following treatment: pain

Study Arms (4)

1

EXPERIMENTAL

Participants will partake in a lifestyle behavioral weight management program for 24 weeks.

Behavioral: Lifestyle Behavioral Weight Management Program

2

EXPERIMENTAL

Participants will partake in pain-coping skills training for 24 weeks.

Behavioral: Pain-Coping Skills Training

3

EXPERIMENTAL

Participants will partake in lifestyle behavioral weight management program plus pain-coping skills training for 24 weeks.

Behavioral: Lifestyle Behavioral Weight Management ProgramBehavioral: Pain-Coping Skills Training

4

ACTIVE COMPARATOR

Participants will receive standard care for 24 weeks.

Other: Standard Care

Interventions

The lifestyle behavioral weight management program will focus on lifestyle, exercise, attitudes, relationships, and nutrition. Participants will attend 12 weekly group sessions, followed by 6 every-other-week group sessions.

13

The pain-coping skills training will focus on minimizing maladaptive over-reactions and enhancing adaptive strategies to control and decrease pain. Participants will attend 12 weekly group sessions, followed by 6 every-other-week group sessions.

23

Standard care will include routine medical care.

4

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meets the American College of Rheumatology criteria for OA
  • Radiographic evidence of OA affecting one or both knees
  • Complaints of chronic knee pain (pain on most days for at least 6 months prior to study entry)
  • No other major weight-bearing joint affected by OA

You may not qualify if:

  • Any significant medical condition or disease that would make study participation unsafe or increase the risk of a significant adverse experience during the course of the study (e.g., myocardial infarction in the 6 months prior to study entry)
  • Currently involved in a regular exercise program
  • An abnormal cardiac response to exercise, such as exercise-induced BT or an abnormal blood pressure response
  • A body mass index (BMI) greater than 42
  • A non-OA inflammatory arthropathy
  • Currently using oral corticosteroids on a regular basis
  • Anticipate to have a knee surgery in the next 18 months (or before the anticipated date of their study completion)
  • Knee surgery (arthroscopic or knee replacement) within a year of enrollment
  • Intraarticular steroid or hyaluronan knee injections in one of both knees within 3 months of enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Morreene Rd. Clinic

Durham, North Carolina, 27705, United States

Location

Related Publications (1)

  • Huebner JL, Landerman LR, Somers TJ, Keefe FJ, Guilak F, Blumenthal JA, Caldwell DS, Kraus VB. Exploratory secondary analyses of a cognitive-behavioral intervention for knee osteoarthritis demonstrate reduction in biomarkers of adipocyte inflammation. Osteoarthritis Cartilage. 2016 Sep;24(9):1528-34. doi: 10.1016/j.joca.2016.04.002. Epub 2016 Apr 16.

MeSH Terms

Conditions

Osteoarthritis

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Francis Keefe, PhD

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 20, 2006

First Posted

March 22, 2006

Study Start

January 1, 2004

Primary Completion

September 1, 2009

Study Completion

September 1, 2009

Last Updated

October 25, 2018

Record last verified: 2013-08

Locations